0
Halozyme Therapeutics, Inc. Banner Image

Halozyme Therapeutics, Inc.

  • Ticker HALO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Halozyme Therapeutics, Inc. Logo Image
  • 201-500 Employees
  • Based in San Diego, California
Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. The company's product portfolio is primarily based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix.
REPORT RATINGS
4.8 / 5.0 (111)

Halozyme Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 111 reviews.

Halozyme Therapeutics, Inc.

Most Recent Annual Report

Halozyme Therapeutics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Halozyme Therapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Halozyme Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!